🔎 Trials Near Me

首页 › 胶质瘤 › 新泽西州

新泽西州 的 胶质瘤 临床试验

新泽西州 有 10 项针对 胶质瘤 的研究正在招募参与者。

新泽西州 的城市

官方研究文本（英文）

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

  • Hackensack University Medical Center, Hackensack
  • Morristown Medical Center, Morristown
  • Newark Beth Israel Medical Center, Newark
  • 以及另外 1 项
招募中1/2 期
12 Months – 21 Years · 所有性别 · 更新于 2026年10月1日 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
  • Rutgers Cancer Institute, New Brunswick
  • Atlantic Health, Summit
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07326566

A Study of Mirdametinib in People With Central Nervous System Tumors

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中1/2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT07539441

Glioma Developmental and HyperActive Ras Tumor (DHART) Board

  • Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (All protocol activities), Middletown
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
招募中观察性研究
18 岁及以上 · 所有性别 · 更新于 2026年8月31日 · NCT05489783

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

  • Rutgers Cancer Institute, New Brunswick
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年8月28日 · NCT05303519

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

  • Joseph M. Sanzari Children's Hospital at Hackensack University Medical Center, Hackensack
招募中1 期
1 至 25 岁 · 所有性别 · 更新于 2026年8月18日 · NCT04485559

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Overlook Medical Center, Summit
招募中2 期
8 岁及以上 · 所有性别 · 更新于 2026年7月27日 · NCT05503797

Pembrolizumab, Olaparib, and Temozolomide for People With Glioma

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年7月22日 · NCT05188508

A Study of 177Lu-PSMA-617 in People With Gliomas

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
招募中1 期
18 岁及以上 · 所有性别 · 更新于 2026年6月4日 · NCT07223034

Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors

  • Hackensack Meridian Health, Inc, Edison
招募中1/2 期
18 岁及以下 · 所有性别 · 更新于 2025年11月20日 · NCT04299191

数据来自 ClinicalTrials.gov，检索日期：2026年10月5日。每项研究自行设定入选标准，由研究团队决定谁能参与。